sábado, 12 de marzo de 2016

Read about Women's Health Research, Essure, HIV and more

Office of Women's Health, FDA

March 2016

Message from the Director

In March, we take time to celebrate and applaud the efforts of women who worked to make America a safer place in areas of medical devices and drug development. This month, celebrate Women’s History Month by reading how women have made historic contributions to health and science at FDA. I also encourage you to learn how FDA has impacted women’s health over the years.
Marsha Henderson, Assistant Commissioner for Women’s Health


2016 OWH Research Grants

OWH has selected 15 research projects for FY 2016 funding.  Projects were selected based on the Research Roadmap 7 priority areas.
The outcomes of the research will help FDA develop innovative approaches to identify and evaluate sex differences and assess the safety and efficacy of medical products used by women.

New Article on Impact of OWH Research on Regulatory Policy

OWH funds research to help FDA evaluate sex differences in product safety and efficacy and to advance the science of women’s health. A new article in the Journal of Women’s Health highlights the impact of OWH-funded research on FDA guidance to industry, product labeling, safety notices, and clinical practice.
Visit the Women’s Health Research page

Update on FDA’s Evaluation of Essure

The FDA announced actions to provide important information about the risks of using Essure and to help women and their doctors be better informed of the potential complications associated with implantable forms of sterilization. FDA issued a new, mandatory clinical study for Essure to determine heightened risks for particular women.
The FDA also intends to require changes to product labeling, including a boxed warning and a Patient Decision Checklist to help to ensure women receive and understand information regarding the benefits and risks of this type of device.The FDA has issued a draft guidance to provide the public an opportunity to comment on the proposed language to be included in these warnings.

Women and Girls HIV/AIDS Awareness Day

On March 10th, use FDA resources to help amplify your voice about HIV/AIDS awareness and encourage women living with HIV to participate in clinical trials. Use these resources in your outreach to teach women about HIV testing, prevention and treatment. 
Download the Women and HIV fact sheet in EnglishSpanish and Other Languages
Use the HIV – Medicines to Help You guide to teach women with HIV about the questions to ask about their medicines.


FDA Welcomes Dr. Califf as the New FDA Commissioner

Robert M. Califf, M.D., was confirmed by the Senate on Wednesday, Feb. 24, 2015, as the Agency’s 22nd Commissioner of Food and Drugs. He is a respected cardiologist and internationally known expert in cardiovascular medicine, health outcomes research, and clinical research.

Safe Spring Break Resources

Are you or someone you know excited about Spring Break? Prepare for a fun time with health and safety tips from FDA. Share these digital tools with your networks to help keep students safe.
Follow @FDAWomen on Twitter for Spring Break tips

New Health Fraud video from FDA Office of Minority Health

In observance of the National Consumer Protection Week, from March 6-12, the FDA is launching a new multimedia and multilingual initiative in English, Spanish, Simplified Chinese, Korean, Vietnamese, and Tagalog to alert consumers of the dangers of imported tainted products falsely marketed as dietary supplements.
Visit the FDA Health Fraud page for more resources
Visit FDA’s Flicker albums for photos of tainted products


March 10, 2016, 2:00 pm to 3:00 pm, Webinar
March 17, 2016, 10:00 am to 4:00 pm, FDA White Oak Campus
March 24, 2016, 8:30am to 4:30pm, UMD Baltimore 

Submit Comments on FDA Regulatory Activities

This docket is open until April 29, 2016.

No hay comentarios:

Publicar un comentario